Pilot Study of Immunization of High Risk Breast Cancer Patients With a Sialyl Lewis-a-Keyhole Limpet Hemocyanin Conjugate Plus the Immunological Adjuvant QS-21.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Breast cancer vaccine (Primary) ; QS 21
- Indications Breast cancer
- Focus Adverse reactions; Pharmacodynamics
- 18 Nov 2020 Biomarkers information updated
- 15 Mar 2013 Planned end date changed from 1 Mar 2010 to 1 Mar 2014 as reported by ClinicalTrials.gov.
- 05 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.